Navigation Links
JCI table of contents: May 24, 2010
Date:5/24/2010

EDITOR'S PICK: Signatures of kidney transplant rejection and acceptance

Three new reports describe biomarkers that identify either kidney transplant recipients likely to maintain excellent and stable allograft function in the absence of immunosuppressive drugs or those at risk of losing their transplants. Peter Heeger and Bernd Schrppel, at Mount Sinai School of Medicine, New York, describe in an accompanying commentary, the importance of these studies and how they might impact the management of patients in the clinic to provide a more personalized treatment regimen.

The most common solid organ transplant procedure performed in the US is kidney transplantation for the treatment of end-stage kidney disease. Transplant recipients must take immunosuppressive drugs for the rest of their lives to prevent rejection of their transplanted kidney, and this has serious negative health consequences. Furthermore, these drugs do not prevent either late-stage rejection of the transplant or transplant failure. To improve long-term outcomes it would be helpful if physicians could determine whether a patient was at risk of losing their transplanted kidney or whether a patient's immune system was sufficiently tolerant of the transplanted kidney that they could stop taking their immunosuppressive drugs.

Two teams of researchers one led by Maria Hernandez-Fuentes, at King's College London, United Kingdom, and the other led by Kenneth Newell, at Emory University, Atlanta, Laurence Turka, at Beth Israel Deaconess Medical Center, Boston, and Vicki Seyfert-Margolis, at Immune Tolerance Network, Bethesda, independently identified and studied rare kidney transplant recipients who have excellent and stable graft function despite no longer taking their immunosuppressive drugs. Both groups identified a signature that was associated with this outcome and both signatures were indicative of immune cells known as B cells having a beneficial role. In contras
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Avoiding Child Obesity: Children Eat Vegetables with Author of New Picture Book, A Hungry Lion in My Tummy
2. Choir Singing May Relieve Irritable Bowel Syndrome
3. The Human Spirit is Indomitable
4. AchooAllergy.com Cools Down with Portable Air Conditioners
5. Millions Are Losing Their Hearing Unnecessarily; Noise-Induced Hearing Loss Is Always Preventable, Says HearUSA Audiologist
6. Unstable chromosome regions are the origin of yeasts brewing capacity
7. The Hastings Center Report table of contents for May/June 2010
8. Physical Therapy Online Continuing Education Courses Undergo an Inevitable Evolution
9. Disabled American Veterans Charitable Services Trust Supports OIF/OEF Veterans Battling PTSD
10. JCI online early table of contents: May 17, 2010
11. Innovative Motorized and Mobile Medical Procedure Table Developed By MTI, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... ... been promoted from Administrative assistant to Executive Assistant to CEO Mitch Gould for ... proven professional, focused on your goals. Kathleen graduated from Florida State University ...
(Date:8/29/2015)... ... 30, 2015 , ... Electronic Informed Consent for Clinical Trials:, ... EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic informed consent is ... Clinical trial sites can now use audio, video and interactivity to educate participants ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... extend and improve the lives of patients, according to a newly published report. ... to read the full article. , The authors of the new paper ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 ... contains 15 seconds of unique footage that users can shrink and stretch in the ... and more. Users can customize color, brightness, scale, speed, range, and flare attributes with ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences announced today ... and Arterosil HP, and that all claims and counterclaims have been irrevocably dismissed. ... (VHS) in the United States District Court for the Southern District of Texas ...
Breaking Medicine News(10 mins):Health News:NPI Appoints New Executive Assistant To CEO 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... But as pandemic seems to ebb, CDC notes a rise ... (HealthDay News) -- U.S. health officials said Monday that ... nationally, even as the number of American children dying from ... Monday by the U.S. Centers for Disease Control and Prevention ...
... , ... released today by Latino Decisions, the Robert Wood Johnson Foundation Center for ... shows a widespread consensus among the Latino/Hispanic electoral about the importance of ... the first time, health care tops the list of national issues identified ...
... , , ... Shock Doctor , is now required equipment in the Top Fuel, Funny ... Hot Rod Association (NHRA) Full Throttle Drag Racing Series, as well as ... NHRA Lucas Oil Drag Racing Series. Eject is the only ...
... ... , ... 30, 2009 -- The 18th annual Texas Autism Conference is set to be ... Bank Center., , , , ,The conference will bring 1,400 attendees and is expected to make ...
... SHORT HILLS, N.J., Nov. 30 Kemin Foods, L.C. ... Technologies, Ltd. ("OmniActive") have reached an amicable settlement of ... No. 5,382,714 ("the ,714 patent") titled "Process for Isolation, ... and Uses Thereof" and the reissues of that patent ...
... , , BRIDGEWATER, N.J., Nov. 30 ... meeting logistics, speaker programs and commercial compliance management software for ... second fastest growing company in the state by NJBIZ, New ... one of the top fifty businesses that have made significant ...
Cached Medicine News:Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2
(Date:8/28/2015)... Aug. 28, 2015  Delays in the launch ... slow down the decision-making process, resulting in missed ... critical for biopharmaceutical companies to develop a tactical ... for quicker and more meaningful insights. ... LLC, nearly three-quarters of benchmarked study participants use ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Pranoprofen Market, 2010-2019" ... discovered by Welfide (Mitsubishi Tanabe Pharma Corporation formerly ... inflammatory drug, pranoprofen was later developed into eye ... trade name of pranopulin for the treatment of ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ... Report on China,s Tobramycin Market, 2010-2019" report to ... whose eye drop and ointment are the most common ... inflammation caused by eye infection. Currently, dozens of enterprises ... produce tobramycin, among which the Top 5 are s.a. ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... 9, 2011 Novavax, Inc. (Nasdaq: NVAX ... Gregory Glenn, Chief Medical Officer of Novavax, will be ... A/H1N1 virus-like particle (VLP) pandemic influenza vaccine clinical trial ... Evaluation of Pandemic Influenza Vaccines in Clinical Trials. The ...
... 9, 2011 Americord Registry , a pioneer in ... proud to announce that it has obtained a provisional human ... Department of Health, becoming the first private umbilical cord blood ... collect umbilical cord blood in the state of New York. ...
Cached Medicine Technology:Americord Becomes Only Family Cord Blood Bank Headquartered in New York City to Hold State Cord Blood License 2
The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
BonePlast is a fast resorbing, osteoconductive bone void filler. By delivering a high dose of calcium to the operative site, BonePlast helps build new bone during the healing process. Packaged in a c...
... patented telescoping plate design integrates ... plate and vertebral column spacer. ... the need for supplemental fixation ... of bone graft to be ...
"Small" redefined for Holter recorders!...
Medicine Products: